MedTrace Logo

Stone and Laser Therapies Post-Market Study (SALT)

NCT06982235 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 238

Last updated 2026-05-12

No results posted yet for this study

Summary

The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.

Conditions

  • Benign Prostate Hypertrophy(BPH)
  • Renal Calculi
  • Ureteral Stones, Kidney Stones
  • Calculi, Urinary
  • Urinary Tract Procedure

Interventions

DEVICE

Ureteroscope system

LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System with intrarenal pressure monitoring

DEVICE

Laser system

Pulse™ 120H Holmium Laser System with MOSES™ 2.0 Technology

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Gita Ghadimi, OD · Boston Scientific Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2029-02-28
Completion
2029-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06982235 on ClinicalTrials.gov